First 100 Claimants Earn Genesis Founder Badge
Are you with Robocath?
Smart robotic solutions for the treatment of cardiovascular diseases
Robocath develops smart robotic platforms for cardiovascular interventions. Key products include R-One, a fully integrated system for remote delivery and adjustment of guidewires and stents during percutaneous coronary intervention (PCI), with CE marking in Europe since 2019, and R-One+, launched in 2023 for coronary angioplasties. Operates in Europe with clinical trials in France for carotid stenting; partnered with MicroPort MedBot for R-ONE approval in China in 2024. Targets interventional cardiologists in hospitals treating cardiovascular diseases.
Active products
1
Top-rated product
R-One
37.5
/100
Company facts
- HQ
- Rouen, France
- Founded
- 2009 · 17 yrs
- Employees
- 70
- Stage
- unknown
- Website
- www.robocath.com
- View profile ↗
Trusted by
- Rennes University Hospitaldeployed 2022surgicalroboticstechnology.com ↗
Milestones
R-ONE vascular intervention robot received NMPA approval in China via MicroPort MedBot JV
Launched R-One+ robotic platform for coronary angioplasties
Completed CARE clinical trial showing 100% success in robotic carotid stenting
Launched R-One+ robotic platform
R-EVOLUTION clinical study results announced
R-One received CE marking in Europe for cardiovascular treatments
R-One received CE marking approval
Medical Training and Testing Center in Rouen acquired R-One robot
Press coverage
- MicroPort® MedBot™ JV's R-ONE®, the World's First Dual-Finger Grasp Mimic Vascular Intervention Robot, Receives Approval in China
MicroPort · Feb 2024
- Robocath's R-One System Studied in France for Robotic Carotid Stenting
EVToday · Oct 2023
- Robocath launches new robotic platform R-One+
Robocath · May 2023
- R-One Robotic Device for Interventional Cardiology Procedures
Medical Device Network
Active products by Robocath
1 shown| # | Category | ||||
|---|---|---|---|---|---|
| 1 | R-One | Surgical / Medical | — | 2018 | 37.5 |